Skip to content. | Skip to navigation


Personal tools

Stuart Peacock

Department Head and Distinguished Scientist

 

S Peacock

Telephone: 604-675-8068
Fax: 604-675-8180
675 W 10th Ave., Vancouver, BC V5Z 1L3

 

Research Roles:

 

Education:

  • PhD (Economics), University of York, UK, 1998
  • MsC (Health Economics), University of York, UK, 1992
  • BA (Industrial Economics), The University of Leeds, UK, 1991

 

Research Interests:

  • Cancer Survivorship 
  • Health Economics and Cancer 
  • Health Services and Policy 
  • Research in Cancer
  • Ethics and Public Engagement


Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship in the Faculty of Health Sciences, Simon Fraser University. He is Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC) and Head of Cancer Control Research at the BC Cancer Research Centre. He is also a member of the Board of Directors of the Canadian Agency for Drugs and Technologies in Health, and past President of the International Society on Priorities in Health Care. He has held university positions in Canada, Australia and the UK. Stuart’s expertise is in the economics of cancer control and quality of life for those impacted by cancer. His main research interests include developing more effective cancer services, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors. 

Active grants that he is a Principal Investigator on:

  • Canadian Centre for Applied Research in Cancer Control 2015-20; Canadian Cancer Society Research Institute
  • Deliberative public engagement to inform cancer control decision-making in Canada. 2017-20; Canadian Institutes of Health Research
  • Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada. 2017-21; Canadian Institutes of Health Research
  • Identifying the most effective multi-attribute utility instrument to guide cancer funding decisions in Canada. 2015-18; Canadian Institutes of Health Research
  • A Multi-Province Approach to Real World Evidence Development for Cancer Drugs: A Case Study of Melanoma. 2017-18; Canadian Institutes of Health Research

Active grants that he is a Co-Investigator on:

  • Silent Genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations. 2018-22; Genome Canada
  • Deciphering the genome biology of relapsed lymphoid cancers to improve patient management. 2018-22; Genome Canada
  • Preference analyses and development of an e-health application to facilitate communication of test results for hereditary cancer syndromes. 2018-20; Canadian Institutes of Health Research
  • Non-Metastatic Castrate Resistant Prostate Cancer: Epidemiology, Clinical Pathways, and Health Care Costs. 2016-18; Prostate Cancer Canada